Emerging issues in teratology: An introduction
Teratogenic exposures
How do we know if an exposure is actually teratogenic in humans?
Evolving knowledge of the teratogenicity of medications in human pregnancy
Laboratory models and their role in assessing teratogenesis
The importance of dysmorphology in the identification of new human teratogens
The role of teratology information services in screening for teratogenic exposures: Challenges and opportunities
Case–control studies for identifying novel teratogens
Monitoring for teratogenic signals: Pregnancy registries and surveillance methods
Genetic basis of susceptibility to teratogen induced birth defects
The art and science of teratogen risk communication
Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States
We don't know what we don't study: The case for research on medication effects in pregnancy